ASSOCIATION OF DIALYSIS ATTENDANCE WITH WAITLISTING OF NORTHERN TERRITORY (NT) BASED END STAGE KIDNEY DISEASE (ESKD) PATIENTS

N KHANAL1,2 , PD LAWTON3, A CASS3, SP MCDONALD1,2

1School of Medicine, University of Adelaide, Adelaide, South Australia; 2Australia & New Zealand Dialysis and Transplant Registry (ANZDATA), South Australian Health and Medical Research Institute (SAHMRI), Adelaide; 3Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory

Aim: To determine the relationship of dialysis attendance with wait-listing for kidney transplantation (KT) among NT based end stage kidney disease (ESKD) patients

Background: Substantial differences exist in the rates of wait-listing of Indigenous ESKD patients. Little is known about the association of dialysis attendance and wait-listing. When dialysis attendance is less than prescribed, it may affect nephrologists’ decision whether or not to refer patient for transplantation due to concerns about outcomes in the post-transplant period. We examined the relationship of facility haemodialysis (FHD) attendance with wait-listing in NT based ESKD patients.

Methods: We used NT hospital separations data, linked with waiting-list, demographic, comorbidity and transplant related information from the ANZDATA registry. Inclusion criteria: NT based ESKD patients who started renal replacement therapy between 28th June 2006 and 31st December 2011, were on FHD and wait-listed by 30th June 2012 censored for transplantation, death, renal recovery and lost to follow-up (n=295). Outcome measure: first active placement on waiting list. Predictors: attendance at FHD during the study period.

Results: Of 295 participants, 266 (90.2%) were Indigenous. Based on mean weekly FHD attendance, patients were divided in three groups: >2.75/week (n=106), 2.5 to 2.75/week (n=55) and <2.5/week (n=134). 21 patients (7.0%) were listed, of whom 15 (71.4%) received deceased donor transplants. Of 19 KT, there were 4 (21.04%) live donor transplants. Compared to >2.75 dialysis sessions/week, likelihood for listing was similar in those attending 2.5-2.75/week (HR 0.8 [95% CI 0.2-4.2]) and < 2.5/ week, (HR 1.7 [0.5-5.5]).

Conclusions: In the NT, rates of placement on the waiting list among those receiving FHD are low. FHD attendance was not associated with wait-listing, although the statistical power was limited.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

/wp-content/uploads/2017/08/Conference-Design-400×400.png

© 2015 - 2016 Conference Design Pty Ltd